Thomas Laughren

Clinical Advisor at Cybin

Thomas Laughren is a former FDA Director for the Division of Psychiatry Products, where he served for 29 years. Dr. Laughren was responsible for overseeing the review of all psychiatric drug development activities conducted under INDs and the review of all NDA’s and supplements for new psychiatric claims. Prior to joining the FDA in September 1983, Dr. Laughren was affiliated with the VA Medical Center in Providence, RI, and was on the faculty of the Brown University Program in Medicine.

Timeline

  • Clinical Advisor

    Current role